Harbr

Overview

Harbr is a healthtech accelerator and venture builder supporting founders in fundraising, scaling, and market expansion. They provide access to dealflow, expertise, and due diligence for funds. Their investment areas include biotechnology, healthcare, health diagnostics, medical, and wellness sectors. Harbr focuses on pre-seed and seed stage companies, with typical investments ranging from 0 to €100,000. Their headquarters are located in the United Kingdom, and they have a presence in Kenya. Harbr's mission is to improve lives by backing and serving digital health and deeptech founders, aiming to invest in new models of wellness, care, and funding. They support game-changing founders and models to attract capital and customers. Harbr offers an Angel Investment Syndicate, collectively investing up to £150,000 in pre-seed and seed stage companies via the Harbr Syndicate SPV. They also provide a Primary Care Accelerator, launched in 2025, which is the UK's first Primary Care Accelerator for startups. Hosted within the nation's leading and largest GP group of nearly 500,000 patients, they leverage the unique role the GP plays at the heart of the UK health and care ecosystem to co-design, test, and scale innovation across the NHS. Additionally, Harbr offers Global Market Access services, helping companies navigate local regulations and establish partnerships in over 44 markets. Their network includes insurers, life sciences, patient groups, and government bodies. Harbr's approach is to leverage their operator backgrounds to proactively support portfolio companies across product, strategy, business model, and market access, sharing dealflow with a large community of healthcare VCs. They aim to democratize data access, make it easy for people to securely discover, access, and use data in a private data and AI marketplace, and monetize data and AI products securely in their own data commerce platform. Harbr's platform empowers technical teams to configure and manage data products while enabling business teams to access, adapt, and use these products effectively. Their leadership team includes David Kim (Co-founder & CEO), Anton Kats (Co-founder & CTO), Ashley Kielbratowski (Co-founder), and Jeff Kielbratowski (Co-founder).

Investment Focus

• Pre-Seed
• Seed
• Healthcare
• Biotechnology
• Medical
• Wellness